Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 115 entries
Sorted by: Best Match Show Resources per page
Successful Management of Diffuse Unilateral Subacute Neuroretinitis with Anthelmintics, and Intravitreal Triamcinolone followed by Laser Photocoagulation.

Journal of ophthalmic & vision research

Lima BS, Ramezani A, Soheilian M, Rastegarpour A, Roshandel D, Sayanjali S.
PMID: 27195096
J Ophthalmic Vis Res. 2016 Jan-Mar;11(1):116-9. doi: 10.4103/2008-322X.180704.

PURPOSE: Diffuse unilateral subacute neuroretinitis (DUSN), a form of posterior uveitis, is secondary to the presence of a highly motile nematode in the intraretinal or subretinal space. Herein, we report a case of DUSN that was successfully managed by...

Cite
Lima BS, Ramezani A, Soheilian M, et al. Successful Management of Diffuse Unilateral Subacute Neuroretinitis with Anthelmintics, and Intravitreal Triamcinolone followed by Laser Photocoagulation. J Ophthalmic Vis Res. 2016;11(1):116-9doi: 10.4103/2008-322X.180704.
Lima, B. S., Ramezani, A., Soheilian, M., Rastegarpour, A., Roshandel, D., & Sayanjali, S. (2016). Successful Management of Diffuse Unilateral Subacute Neuroretinitis with Anthelmintics, and Intravitreal Triamcinolone followed by Laser Photocoagulation. Journal of ophthalmic & vision research, 11(1), 116-9. https://doi.org/10.4103/2008-322X.180704
Lima, Behzad Safarpour, et al. "Successful Management of Diffuse Unilateral Subacute Neuroretinitis with Anthelmintics, and Intravitreal Triamcinolone followed by Laser Photocoagulation." Journal of ophthalmic & vision research vol. 11,1 (2016): 116-9. doi: https://doi.org/10.4103/2008-322X.180704
Lima BS, Ramezani A, Soheilian M, Rastegarpour A, Roshandel D, Sayanjali S. Successful Management of Diffuse Unilateral Subacute Neuroretinitis with Anthelmintics, and Intravitreal Triamcinolone followed by Laser Photocoagulation. J Ophthalmic Vis Res. 2016 Jan-Mar;11(1):116-9. doi: 10.4103/2008-322X.180704. PMID: 27195096; PMCID: PMC4860977.
Copy Download .nbib Format: NLM
Calixarene-Mediated Liquid Membrane Transport of Choline Conjugates 2: Transport of Drug-Choline Conjugates and Neurotransmitters.

European journal of organic chemistry

Adhikari BB, Roshandel S, Fujii A, Schramm MP.
PMID: 26161035
European J Org Chem. 2015 Apr 01;2015(12):2683-2690. doi: 10.1002/ejoc.201403519.

Lower rim carboxylic acid calix[

Cite
Adhikari BB, Roshandel S, Fujii A, et al. Calixarene-Mediated Liquid Membrane Transport of Choline Conjugates 2: Transport of Drug-Choline Conjugates and Neurotransmitters. European J Org Chem. 2015;2015(12):2683-2690doi: 10.1002/ejoc.201403519.
Adhikari, B. B., Roshandel, S., Fujii, A., & Schramm, M. P. (2015). Calixarene-Mediated Liquid Membrane Transport of Choline Conjugates 2: Transport of Drug-Choline Conjugates and Neurotransmitters. European journal of organic chemistry, 2015(12), 2683-2690. https://doi.org/10.1002/ejoc.201403519
Adhikari, Birendra Babu, et al. "Calixarene-Mediated Liquid Membrane Transport of Choline Conjugates 2: Transport of Drug-Choline Conjugates and Neurotransmitters." European journal of organic chemistry vol. 2015,12 (2015): 2683-2690. doi: https://doi.org/10.1002/ejoc.201403519
Adhikari BB, Roshandel S, Fujii A, Schramm MP. Calixarene-Mediated Liquid Membrane Transport of Choline Conjugates 2: Transport of Drug-Choline Conjugates and Neurotransmitters. European J Org Chem. 2015 Apr 01;2015(12):2683-2690. doi: 10.1002/ejoc.201403519. PMID: 26161035; PMCID: PMC4495001.
Copy Download .nbib Format: NLM
Should we look for celiac disease in irritable bowel syndrome?.

Oman medical journal

Amiriani T, Besharat S, Roshandel G, Shalizar A.
PMID: 22043384
Oman Med J. 2011 Jan;26(1):59-60. doi: 10.5001/omj.2011.16.

No abstract available.

Cite
Amiriani T, Besharat S, Roshandel G, et al. Should we look for celiac disease in irritable bowel syndrome?. Oman Med J. 2011;26(1):59-60doi: 10.5001/omj.2011.16.
Amiriani, T., Besharat, S., Roshandel, G., & Shalizar, A. (2011). Should we look for celiac disease in irritable bowel syndrome?. Oman medical journal, 26(1), 59-60. https://doi.org/10.5001/omj.2011.16
Amiriani, Taghi, et al. "Should we look for celiac disease in irritable bowel syndrome?." Oman medical journal vol. 26,1 (2011): 59-60. doi: https://doi.org/10.5001/omj.2011.16
Amiriani T, Besharat S, Roshandel G, Shalizar A. Should we look for celiac disease in irritable bowel syndrome?. Oman Med J. 2011 Jan;26(1):59-60. doi: 10.5001/omj.2011.16. PMID: 22043384; PMCID: PMC3191611.
Copy Download .nbib Format: NLM
Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use.

Bone

Ebetino FH, Sun S, Cherian P, Roshandel S, Neighbors JD, Hu E, Dunford JE, Sedghizadeh PP, McKenna CE, Srinivasan V, Boeckman RK, Russell RGG.
PMID: 34896359
Bone. 2021 Dec 08;156:116289. doi: 10.1016/j.bone.2021.116289. Epub 2021 Dec 08.

The bisphosphonates ((HO)

Cite
Ebetino FH, Sun S, Cherian P, et al. Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use. Bone. 2021;156:116289doi: 10.1016/j.bone.2021.116289.
Ebetino, F. H., Sun, S., Cherian, P., Roshandel, S., Neighbors, J. D., Hu, E., Dunford, J. E., Sedghizadeh, P. P., McKenna, C. E., Srinivasan, V., Boeckman, R. K., & Russell, R. G. G. (2021). Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use. Bone, 156116289. https://doi.org/10.1016/j.bone.2021.116289
Ebetino, Frank H, et al. "Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use." Bone vol. 156 (2021): 116289. doi: https://doi.org/10.1016/j.bone.2021.116289
Ebetino FH, Sun S, Cherian P, Roshandel S, Neighbors JD, Hu E, Dunford JE, Sedghizadeh PP, McKenna CE, Srinivasan V, Boeckman RK, Russell RGG. Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use. Bone. 2021 Dec 08;156:116289. doi: 10.1016/j.bone.2021.116289. Epub 2021 Dec 08. PMID: 34896359.
Copy Download .nbib Format: NLM
Diagnostic performance of lung ultrasound compared to CT scan in the diagnosis of pulmonary lesions of COVID-19 induced pneumonia: a preliminary study.

Virusdisease

Roshandel J, Alahyari S, Khazaei M, Asgari R, Moharamzad Y, Zarei E, Sanei Taheri M.
PMID: 34426793
Virusdisease. 2021 Aug 18;1-7. doi: 10.1007/s13337-021-00736-w. Epub 2021 Aug 18.

Chest CT scan is currently used to assess the extent of lung involvement in patients with the coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the diagnostic performance of lung ultrasound in the diagnosis of...

Cite
Roshandel J, Alahyari S, Khazaei M, et al. Diagnostic performance of lung ultrasound compared to CT scan in the diagnosis of pulmonary lesions of COVID-19 induced pneumonia: a preliminary study. Virusdisease. 2021;1-7doi: 10.1007/s13337-021-00736-w.
Roshandel, J., Alahyari, S., Khazaei, M., Asgari, R., Moharamzad, Y., Zarei, E., & Sanei Taheri, M. (2021). Diagnostic performance of lung ultrasound compared to CT scan in the diagnosis of pulmonary lesions of COVID-19 induced pneumonia: a preliminary study. Virusdisease, 1-7. https://doi.org/10.1007/s13337-021-00736-w
Roshandel, Jafar, et al. "Diagnostic performance of lung ultrasound compared to CT scan in the diagnosis of pulmonary lesions of COVID-19 induced pneumonia: a preliminary study." Virusdisease vol. (2021): 1-7. doi: https://doi.org/10.1007/s13337-021-00736-w
Roshandel J, Alahyari S, Khazaei M, Asgari R, Moharamzad Y, Zarei E, Sanei Taheri M. Diagnostic performance of lung ultrasound compared to CT scan in the diagnosis of pulmonary lesions of COVID-19 induced pneumonia: a preliminary study. Virusdisease. 2021 Aug 18;1-7. doi: 10.1007/s13337-021-00736-w. Epub 2021 Aug 18. PMID: 34426793; PMCID: PMC8372226.
Copy Download .nbib Format: NLM
Clinical application of stem cell therapy in neurogenic bladder: a systematic review and meta-analysis.

International urogynecology journal

Salehi-Pourmehr H, Nouri O, Naseri A, Roshangar L, Rahbarghazi R, Sadigh-Eteghad S, Mahmoudi J, Mostafaei H, Roshandel MR, Hoseini L, Abolhasanpour N, Mostafaei A, Hajebrahimi S, Hashim H.
PMID: 34767058
Int Urogynecol J. 2021 Nov 12; doi: 10.1007/s00192-021-04986-6. Epub 2021 Nov 12.

INTRODUCTION AND HYPOTHESIS: This review aims to investigate the effect of stem cell (SC) therapy on the management of neurogenic bladder (NGB) in four neurological diseases, including spinal cord injury (SCI), Parkinson's disease (PD), multiple sclerosis (MS), and stroke,...

Cite
Salehi-Pourmehr H, Nouri O, Naseri A, et al. Clinical application of stem cell therapy in neurogenic bladder: a systematic review and meta-analysis. Int Urogynecol J. 2021;doi: 10.1007/s00192-021-04986-6.
Salehi-Pourmehr, H., Nouri, O., Naseri, A., Roshangar, L., Rahbarghazi, R., Sadigh-Eteghad, S., Mahmoudi, J., Mostafaei, H., Roshandel, M. R., Hoseini, L., Abolhasanpour, N., Mostafaei, A., Hajebrahimi, S., & Hashim, H. (2021). Clinical application of stem cell therapy in neurogenic bladder: a systematic review and meta-analysis. International urogynecology journal, . https://doi.org/10.1007/s00192-021-04986-6
Salehi-Pourmehr, Hanieh, et al. "Clinical application of stem cell therapy in neurogenic bladder: a systematic review and meta-analysis." International urogynecology journal vol. (2021). doi: https://doi.org/10.1007/s00192-021-04986-6
Salehi-Pourmehr H, Nouri O, Naseri A, Roshangar L, Rahbarghazi R, Sadigh-Eteghad S, Mahmoudi J, Mostafaei H, Roshandel MR, Hoseini L, Abolhasanpour N, Mostafaei A, Hajebrahimi S, Hashim H. Clinical application of stem cell therapy in neurogenic bladder: a systematic review and meta-analysis. Int Urogynecol J. 2021 Nov 12; doi: 10.1007/s00192-021-04986-6. Epub 2021 Nov 12. PMID: 34767058.
Copy Download .nbib Format: NLM
The association of disease type, pre-transplant hemoglobin level and platelet count with transfusion requirement after autologous hematopoietic stem cell transplantation.

Caspian journal of internal medicine

Tabasi S, Parkhideh S, Roshandel E, Karami S, Saeedi A, Jabbari A, Hajifathali A.
PMID: 34820061
Caspian J Intern Med. 2021;12(4):544-550. doi: 10.22088/cjim.12.4.544.

BACKGROUND: Autologous hematopoietic stem cell transplantation (auto-HSCT) has become an effective treatment for a wide range of hematologic and non-hematologic diseases. Patients undergoing HSCT might require multiple platelets and red blood cell (RBC) transfusions during aplasia phase until engraftment,...

Cite
Tabasi S, Parkhideh S, Roshandel E, et al. The association of disease type, pre-transplant hemoglobin level and platelet count with transfusion requirement after autologous hematopoietic stem cell transplantation. Caspian J Intern Med. 2021;12(4):544-550doi: 10.22088/cjim.12.4.544.
Tabasi, S., Parkhideh, S., Roshandel, E., Karami, S., Saeedi, A., Jabbari, A., & Hajifathali, A. (2021). The association of disease type, pre-transplant hemoglobin level and platelet count with transfusion requirement after autologous hematopoietic stem cell transplantation. Caspian journal of internal medicine, 12(4), 544-550. https://doi.org/10.22088/cjim.12.4.544
Tabasi, Shabnam, et al. "The association of disease type, pre-transplant hemoglobin level and platelet count with transfusion requirement after autologous hematopoietic stem cell transplantation." Caspian journal of internal medicine vol. 12,4 (2021): 544-550. doi: https://doi.org/10.22088/cjim.12.4.544
Tabasi S, Parkhideh S, Roshandel E, Karami S, Saeedi A, Jabbari A, Hajifathali A. The association of disease type, pre-transplant hemoglobin level and platelet count with transfusion requirement after autologous hematopoietic stem cell transplantation. Caspian J Intern Med. 2021;12(4):544-550. doi: 10.22088/cjim.12.4.544. PMID: 34820061; PMCID: PMC8590401.
Copy Download .nbib Format: NLM
Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use.

Bone

Ebetino FH, Sun S, Cherian P, Roshandel S, Neighbors JD, Hu E, Dunford JE, Sedghizadeh PP, McKenna CE, Srinivasan V, Boeckman RK, Russell RGG.
PMID: 34896359
Bone. 2021 Dec 08;156:116289. doi: 10.1016/j.bone.2021.116289. Epub 2021 Dec 08.

The bisphosphonates ((HO)

Cite
Ebetino FH, Sun S, Cherian P, et al. Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use. Bone. 2021;156:116289doi: 10.1016/j.bone.2021.116289.
Ebetino, F. H., Sun, S., Cherian, P., Roshandel, S., Neighbors, J. D., Hu, E., Dunford, J. E., Sedghizadeh, P. P., McKenna, C. E., Srinivasan, V., Boeckman, R. K., & Russell, R. G. G. (2021). Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use. Bone, 156116289. https://doi.org/10.1016/j.bone.2021.116289
Ebetino, Frank H, et al. "Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use." Bone vol. 156 (2021): 116289. doi: https://doi.org/10.1016/j.bone.2021.116289
Ebetino FH, Sun S, Cherian P, Roshandel S, Neighbors JD, Hu E, Dunford JE, Sedghizadeh PP, McKenna CE, Srinivasan V, Boeckman RK, Russell RGG. Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use. Bone. 2021 Dec 08;156:116289. doi: 10.1016/j.bone.2021.116289. Epub 2021 Dec 08. PMID: 34896359.
Copy Download .nbib Format: NLM
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS).

Pulmonology

Hashemian SM, Shafigh N, Afzal G, Jamaati H, Tabarsi P, Marjani M, Malekmohammad M, Mortazavi SM, Khoundabi B, Mansouri D, Moniri A, Hajifathali A, Roshandel E, Mortaz E, Adcock IM.
PMID: 33358260
Pulmonology. 2021 Nov-Dec;27(6):486-492. doi: 10.1016/j.pulmoe.2020.10.017. Epub 2020 Dec 04.

BACKGROUND: In December 2019, pneumonia associated with a novel coronavirus (COVID-19) was reported in Wuhan, China. Acute respiratory distress syndrome (ARDS) is the most frequently observed complication in COVID-19 patients with high mortality rates.OBJECTIVE OF STUDY: To observe the...

Cite
Hashemian SM, Shafigh N, Afzal G, et al. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2020;27(6):486-492doi: 10.1016/j.pulmoe.2020.10.017.
Hashemian, S. M., Shafigh, N., Afzal, G., Jamaati, H., Tabarsi, P., Marjani, M., Malekmohammad, M., Mortazavi, S. M., Khoundabi, B., Mansouri, D., Moniri, A., Hajifathali, A., Roshandel, E., Mortaz, E., & Adcock, I. M. (2021). Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Pulmonology, 27(6), 486-492. https://doi.org/10.1016/j.pulmoe.2020.10.017
Hashemian, Seyed MohammadReza, et al. "Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)." Pulmonology vol. 27,6 (2021): 486-492. doi: https://doi.org/10.1016/j.pulmoe.2020.10.017
Hashemian SM, Shafigh N, Afzal G, Jamaati H, Tabarsi P, Marjani M, Malekmohammad M, Mortazavi SM, Khoundabi B, Mansouri D, Moniri A, Hajifathali A, Roshandel E, Mortaz E, Adcock IM. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2021 Nov-Dec;27(6):486-492. doi: 10.1016/j.pulmoe.2020.10.017. Epub 2020 Dec 04. PMID: 33358260; PMCID: PMC7834188.
Copy Download .nbib Format: NLM
Treatment Failure in Acute Myeloid Leukemia: Focus on the Role of Extracellular Vesicles.

Leukemia research

Mirfakhraie R, Noorazar L, Mohammadian M, Hajifathali A, Gholizadeh M, Salimi M, Sankanian G, Roshandel E, Mehdizadeh M.
PMID: 34808592
Leuk Res. 2021 Nov 16;112:106751. doi: 10.1016/j.leukres.2021.106751. Epub 2021 Nov 16.

Acute myeloblastic leukemia (AML) is one of the most common types of blood malignancies that results in an AML-associated high mortality rate each year. Several causes have been reported as prognostic factors for AML in children and adults, the...

Cite
Mirfakhraie R, Noorazar L, Mohammadian M, et al. Treatment Failure in Acute Myeloid Leukemia: Focus on the Role of Extracellular Vesicles. Leuk Res. 2021;112:106751doi: 10.1016/j.leukres.2021.106751.
Mirfakhraie, R., Noorazar, L., Mohammadian, M., Hajifathali, A., Gholizadeh, M., Salimi, M., Sankanian, G., Roshandel, E., & Mehdizadeh, M. (2021). Treatment Failure in Acute Myeloid Leukemia: Focus on the Role of Extracellular Vesicles. Leukemia research, 112106751. https://doi.org/10.1016/j.leukres.2021.106751
Mirfakhraie, Reza, et al. "Treatment Failure in Acute Myeloid Leukemia: Focus on the Role of Extracellular Vesicles." Leukemia research vol. 112 (2021): 106751. doi: https://doi.org/10.1016/j.leukres.2021.106751
Mirfakhraie R, Noorazar L, Mohammadian M, Hajifathali A, Gholizadeh M, Salimi M, Sankanian G, Roshandel E, Mehdizadeh M. Treatment Failure in Acute Myeloid Leukemia: Focus on the Role of Extracellular Vesicles. Leuk Res. 2021 Nov 16;112:106751. doi: 10.1016/j.leukres.2021.106751. Epub 2021 Nov 16. PMID: 34808592.
Copy Download .nbib Format: NLM
Untargeted Metabolomics: Biochemical Perturbations in Golestan Cohort Study Opium Users Inform Intervention Strategies.

Frontiers in nutrition

Li YY, Ghanbari R, Pathmasiri W, McRitchie S, Poustchi H, Shayanrad A, Roshandel G, Etemadi A, Pollock JD, Malekzadeh R, Sumner SCJ.
PMID: 33415121
Front Nutr. 2020 Dec 22;7:584585. doi: 10.3389/fnut.2020.584585. eCollection 2020.

No abstract available.

Cite
Li YY, Ghanbari R, Pathmasiri W, et al. Untargeted Metabolomics: Biochemical Perturbations in Golestan Cohort Study Opium Users Inform Intervention Strategies. Front Nutr. 2020;7:584585doi: 10.3389/fnut.2020.584585.
Li, Y. Y., Ghanbari, R., Pathmasiri, W., McRitchie, S., Poustchi, H., Shayanrad, A., Roshandel, G., Etemadi, A., Pollock, J. D., Malekzadeh, R., & Sumner, S. C. J. (2020). Untargeted Metabolomics: Biochemical Perturbations in Golestan Cohort Study Opium Users Inform Intervention Strategies. Frontiers in nutrition, 7584585. https://doi.org/10.3389/fnut.2020.584585
Li, Yuan-Yuan, et al. "Untargeted Metabolomics: Biochemical Perturbations in Golestan Cohort Study Opium Users Inform Intervention Strategies." Frontiers in nutrition vol. 7 (2020): 584585. doi: https://doi.org/10.3389/fnut.2020.584585
Li YY, Ghanbari R, Pathmasiri W, McRitchie S, Poustchi H, Shayanrad A, Roshandel G, Etemadi A, Pollock JD, Malekzadeh R, Sumner SCJ. Untargeted Metabolomics: Biochemical Perturbations in Golestan Cohort Study Opium Users Inform Intervention Strategies. Front Nutr. 2020 Dec 22;7:584585. doi: 10.3389/fnut.2020.584585. eCollection 2020. PMID: 33415121; PMCID: PMC7783045.
Copy Download .nbib Format: NLM
Pre-and Post-Transplant Serum Lactate Dehydrogenase Levels as a Predictive Marker for Patient Survival and Engraftment in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Reports of biochemistry & molecular biology

Roshandel E, Parkhideh S, Ghaffari Nazari H, Mehdizadeh M, Bonakchi H, Sankanian G, Hajifathali A.
PMID: 34604410
Rep Biochem Mol Biol. 2021 Jul;10(2):204-215. doi: 10.52547/rbmb.10.2.204.

BACKGROUND: The discovery of biomarkers to predict the development of complications associated with hematopoietic stem cell transplantation (HSCT) offers a potential avenue for the early identification and treatment of these life-threatening consequences. Serum lactate dehydrogenase (sLDH) has been identified...

Cite
Roshandel E, Parkhideh S, Ghaffari Nazari H, et al. Pre-and Post-Transplant Serum Lactate Dehydrogenase Levels as a Predictive Marker for Patient Survival and Engraftment in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Rep Biochem Mol Biol. 2021;10(2):204-215doi: 10.52547/rbmb.10.2.204.
Roshandel, E., Parkhideh, S., Ghaffari Nazari, H., Mehdizadeh, M., Bonakchi, H., Sankanian, G., & Hajifathali, A. (2021). Pre-and Post-Transplant Serum Lactate Dehydrogenase Levels as a Predictive Marker for Patient Survival and Engraftment in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Reports of biochemistry & molecular biology, 10(2), 204-215. https://doi.org/10.52547/rbmb.10.2.204
Roshandel, Elham, et al. "Pre-and Post-Transplant Serum Lactate Dehydrogenase Levels as a Predictive Marker for Patient Survival and Engraftment in Allogeneic Hematopoietic Stem Cell Transplant Recipients." Reports of biochemistry & molecular biology vol. 10,2 (2021): 204-215. doi: https://doi.org/10.52547/rbmb.10.2.204
Roshandel E, Parkhideh S, Ghaffari Nazari H, Mehdizadeh M, Bonakchi H, Sankanian G, Hajifathali A. Pre-and Post-Transplant Serum Lactate Dehydrogenase Levels as a Predictive Marker for Patient Survival and Engraftment in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Rep Biochem Mol Biol. 2021 Jul;10(2):204-215. doi: 10.52547/rbmb.10.2.204. PMID: 34604410; PMCID: PMC8480290.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 115 entries